CONTINEUM THERAPEUTICS INC-A
CTNM · NASDAQ
Updated at 2026-10-14 09:03:13
- Today's High
- $8.94
- Today’s Low
- $8.09
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $9.90
- Previous Close
- $8.56
- Volume
- 8.46M
- Market Cap
- $322.22M
- P/E Ratio
- --
- EPS
- $-1.73
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3565 GENERAL ATOMICS COURT, SAN DIEGO, CA, UNITED STATES, 92121
- Country
- US
- Listing Date
- 2024-04-05
- Fiscal Year End
- December
- Shares Outstanding
- 37.39M
- CIK
- 0001855175
- Website
- www.contineum-tx.com
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$17.42M
2026-03-31
$16.9M
2025-12-31
$17.11M
2025-09-30
$14.93M
Net Income
2026-06-30
-$15.15M
2026-03-31
-$14.45M
2025-12-31
-$15.15M
2025-09-30
-$12.79M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.40
2026-03-31
$-0.39
2025-12-31
$-0.49
2025-09-30
$-0.45
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$17.29M
2026-03-31
-$16.82M
2025-12-31
-$17.03M
2025-09-30
-$14.85M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $17.42M | $16.9M | $17.11M | $14.93M |
| Net Income | -$15.15M | -$14.45M | -$15.15M | -$12.79M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.40 | $-0.39 | $-0.49 | $-0.45 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$17.29M | -$16.82M | -$17.03M | -$14.85M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.